AI Article Synopsis

  • - The study examines the safety of using CP-1, a cryoprotectant medium, in hematopoietic stem cell transplants, particularly in comparison to the standard cryoprotectant DMSO.
  • - Results indicate that while the incidence of grade 2 infusion-related adverse events (HCI-AEs) was higher in the CP-1 group, there was no significant difference in more severe HCI-AEs between CP-1 and non-CP-1 groups.
  • - Toxicity tests in rats showed no significant adverse effects from CP-1, suggesting that it can be safely used in peripheral blood stem cell transplants.

Article Abstract

Background: The standard cryoprotectant for human cellular products is dimethyl sulfoxide (DMSO), which is associated with hematopoietic cell infusion-related adverse events (HCI-AEs) in hematopoietic stem cell transplantation including peripheral blood stem cell (PBSC) transplantation (PBSCT). DMSO is often used with hydroxyethyl starch (HES), which reduces DMSO concentration while maintaining the postthaw cell recovery. The cryoprotectant medium CP-1 (Kyokuto Pharmaceutical Industrial) is widely used in Japan. After mixture of a product with CP-1, DMSO and HES concentrations are 5% and 6%, respectively. However, the safety profile of CP-1 in association with HCI-AEs has not been investigated.

Study Design And Methods: To compare CP-1 with other cryoprotectants, we conducted a subgroup analysis of PBSCT recipients in a prospective surveillance study for HCI-AEs. Moreover, we validated the toxicity of CP-1 in 90 rats following various dose administration.

Results: The PBSC products cryopreserved with CP-1 (CP-1 group) and those with other cryoprotectants, mainly 10% DMSO (non-CP-1 group), were infused into 418 and 58 recipients, respectively. The rate of ≥grade 2 HCI-AEs was higher in the CP-1 group, but that of overall or ≥grade 3 HCI-AEs was not significantly different, compared to the non-CP-1 group. Similarly, after propensity score matching, ≥grade 2 HCI-AEs were more frequent in the CP-1 group, but the ≥grade 3 HCI-AE rate did not differ significantly between the groups. No significant toxicity was detected regardless of the CP-1 dose in the 90 rats.

Conclusions: Infusion of a CP-1-containing PBSC product is feasible with the respect of HCI-AEs.

Download full-text PDF

Source
http://dx.doi.org/10.1111/trf.16877DOI Listing

Publication Analysis

Top Keywords

cp-1 group
12
cp-1
10
hematopoietic cell
8
cell infusion-related
8
infusion-related adverse
8
adverse events
8
stem cell
8
non-cp-1 group
8
≥grade hci-aes
8
hci-aes
7

Similar Publications

Article Synopsis
  • The study aimed to evaluate how implementing the Enhanced Recovery After Surgery (ERAS) program affected treatment costs at a university hospital, focusing on a group of 604 patients.
  • Researchers analyzed three patient groups based on ERAS clinical protocols and found significant reductions in the length of hospital stay (LOS) and direct treatment costs.
  • The results highlighted major improvements, especially in the oncogynaecology group, leading to more available hospital capacity and lower costs for antibiotics and lab tests.
View Article and Find Full Text PDF

Introduction: Bladder pain syndrome/Interstitial cystitis (BPS/IC) is clinically of diverse types because different causes contribute to the development of their symptoms. It is important to classify patients into various groups based on the possible etiopathogenesis of their condition. Treatment may be tailored to each specific group according to the possible cause.

View Article and Find Full Text PDF

Background: Time restricted eating (TRE) is a dietary strategy that may improve metabolic health. However, no studies have compared TRE with current practice (CP) in dietetics.

Hypothesis: TRE will not be inferior to CP to improve glycaemic control in individuals at risk of type 2 diabetes (T2D).

View Article and Find Full Text PDF

Two new two-dimensional (2D) coordination polymers (CPs), namely, poly[diaqua[μ-2,2'-(1,3,5,7-tetraoxo-1,2,3,5,6,7-hexahydropyrrolo[3,4-f]isoindole-2,6-diyl)diacetato-κO:O':O'':O''']cadmium(II)], [Cd(CHNO)(HO)] (1), and poly[[tetraaqua[μ-2,2'-(1,3,5,7-tetraoxo-1,2,3,5,6,7-hexahydropyrrolo[3,4-f]isoindole-2,6-diyl)diacetato-κO:O':O'':O'''][μ-2,2'-(1,3,5,7-tetraoxo-1,2,3,5,6,7-hexahydropyrrolo[3,4-f]isoindole-2,6-diyl)diacetato-κO:O']dizinc(II)] dihydrate], {[Zn(CHNO(HO)]·HO} (2), have been synthesized by the microwave-irradiated reaction of Cd(CHCOO)·2HO and Zn(CHCOO)·2HO, respectively, with N,N'-bis(glycinyl)pyromellitic diimide {BGPD, namely, 2,2'-(1,3,5,7-tetraoxo-1,2,3,5,6,7-hexahydropyrrolo[3,4-f]isoindole-2,6-diyl)diacetic acid, HL}. In the crystal structure of 1, the Cd ion is six-coordinated by four carboxylate O atoms from four symmetry-related L dianions and two coordinated water molecules, furnishing an octahedral coordination geometry. The bridging L dianion links four symmetry-related Cd cations into a 2D layer-like structure with a 3,4-connected bex topology.

View Article and Find Full Text PDF

Spatial confined synthesis of submicron Fe-MoS with abundant surface cationic groups and sulfur vacancies for enhanced peroxymonosulfate activation.

Environ Technol

August 2024

National Engineering Lab of Textile Fiber Materials & Processing Technology (Zhejiang), Zhejiang Sci-Tech University, Hangzhou, People's Republic of China.

The widespread use of emerging refractory organic contaminants poses a significant threat to human health, prompting the need for a cost-effective and efficient removal strategy. While the iron ions/PMS system effectively removes organic pollutants, slow Fe to Fe transformation hampers its efficiency, and the homogeneous distribution of iron ions complicates separation, resulting in secondary sludge pollution. Herein, we developed a novel submicron Fe-MoS (S-Fe-MoS) catalyst with abundant surface cationic groups and sulfur vacancy through a cationic polyacrylamide aerogels (CPAMA) confined hydrothermal synthesis strategy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!